{"slideshow_credits": null, "snippet": "Endo Health Solutions, a health care company known for its pain medication, has reached a deal to acquire a Canadian specialty drug company, Paladin Labs, for $1.6 billion in stock and cash.", "abstract": "Endo Health Solutions, a health care company known for its pain medication, has reached a deal to acquire a Canadian specialty drug company, Paladin Labs, for $1.6 billion in stock and cash.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Dealbook", "role": "reported", "rank": 1, "organization": ""}], "original": "By DEALBOOK"}, "web_url": "http://dealbook.nytimes.com/2013/11/05/endo-health-to-buy-specialty-drug-maker-for-1-6-billion/", "lead_paragraph": null, "headline": {"main": "Endo Health to Buy Specialty Drug Maker for $1.6 Billion", "kicker": "DealBook"}, "_id": "5278e81638f0d8702adc8555", "word_count": "332", "multimedia": [], "pub_date": "2013-11-05T07:42:20Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "Endo Pharmaceuticals Holdings Inc", "rank": "1"}, {"name": "organizations", "value": "Paladin Laboratories Incorporated", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Leishmaniasis", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}